Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.5
94.78%
Every year
—
-99.25%
40%
—
5 Years
Score6.5
Net Growth94.78%
Net TrendEvery year
Net Income Consistency—
Rev Growth-99.25%
Rev Trend40%
Revenue Consistency—
Alaunos Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 0.00 to $ 5K and net income went from -$ 78M to -$ 4M. Revenue increased in 2 of those 5 years; net income in every one.
Between 2015 and 2025, revenue declined from $ 4M to $ 5K and net income went from -$ 120M to -$ 4M. Revenue increased in 3 of those 10 years; net income in 9.
Alaunos Therapeutics Inc currently holds a 5-year HDB Score of 6.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 1.99 | — |
1 Year2025-08-13 | $ 2.39 | -16.74% |
5 Years2021-08-13 | $ 267.00 | -99.25% |
10 Years2016-08-12 | $ 819.00 | -99.76% |
20 Years2006-08-11 | $ 727.50 | -99.73% |
All Time2005-08-24 | $ 2.4K | -99.92% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2005-08-24 |
|---|---|---|---|---|---|---|
| Price | $ 1.99 | $ 2.39 | $ 267.00 | $ 819.00 | $ 727.50 | $ 2.4K |
| Return | — | -16.74% | -99.25% | -99.76% | -99.73% | -99.92% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3K | -$ 4M | $ 354K |
| 2025 | $ 5K | -$ 4M | $ 1M |
| 2024 | $ 10K | -$ 4M | $ 1M |
| 2023 | $ 5K | -$ 35M | $ 6M |
| 2022 | $ 2M | -$ 37M | $ 39M |
| 2021 | $ 398K | -$ 78M | $ 76M |
| 2020 | $ 0.00 | -$ 78M | $ 115M |
| 2019 | $ 0.00 | -$ 117M | $ 79M |
| 2018 | $ 146K | -$ 53M | $ 61M |
| 2017 | $ 6M | -$ 54M | $ 70M |
| 2016 | $ 6M | -$ 165M | $ 81M |
| 2015 | $ 4M | -$ 120M | $ 140M |
| 2014 | $ 1M | -$ 31M | $ 42M |
| 2013 | $ 800K | -$ 57M | $ 68M |
| 2012 | $ 800K | -$ 96M | $ 73M |
| 2011 | $ 667K | -$ 63M | $ 104M |
| 2010 | -$ 32M | $ 60M | |
| 2009 | -$ 7M | $ 48M | |
| 2008 | -$ 25M | $ 11M | |
| 2007 | -$ 26M | $ 35M | |
| 2006 | -$ 17M | $ 28M | |
| IPO2005 | -$ 9M | $ 8M |
Explore beyond TCRT
You're looking at Alaunos Therapeutics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
